Φορτώνει......
The Role of GSK3 and its Reversal with GSK3 Antagonism in Everolimus Resistance
Pancreatic neuroendocrine tumors (panNETs) are often inoperable at diagnosis. The mTORC1 inhibitor everolimus has been approved for the treatment of advanced NETs. However, the regular development of resistance to everolimus limits its clinical efficacy. We established two independent everolimus-res...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Endocr Relat Cancer |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7439002/ https://ncbi.nlm.nih.gov/pubmed/29895527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-18-0159 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|